3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia
15
Leukemia, Lymphocytic, Chronic, B-Cell
10
Lymphoma
9
Myelodysplastic Syndromes
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
6
Multiple Myeloma
5
Myeloproliferative Disorders
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Graft vs Host Disease
4
Neoplasms, Plasma Cell
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, Myeloid, Chronic-Phase
3
Leukemia, Myeloid, Acute
3
Hematologic Neoplasms
3
Congenital Abnormalities
3
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, T-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Accelerated Phase
2
Hematologic Diseases
2
Blast Crisis
2
Anemia, Aplastic
2
Waldenstrom Macroglobulinemia
1
Unrecognized Condition: Mature B or T-cell Neoplasm
1
Thrombocythemia, Essential
1
Thalassemia
1
Primary Myelofibrosis
1
Interventions
fludarabine phosphate
5
Cyclophosphamide
4
Whole-Body Irradiation
3
Cyclosporine
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
fludarabine
2
Stem Cell Transplantation
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Methylprednisolone
2
Hydroxyurea
2
Busulfan
2
Antilymphocyte Serum
2
ruxolitinib
1
nelarabine
1
fresolimumab
1
arsenous acid
1
Watchful Waiting
1
Thiotepa
1
Tetradecanoylphorbol Acetate
1
Surveys and Questionnaires
1
RG7388
1
Phlebotomy
1
Oxycodone
1
Observation
1
Nivolumab
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Mycophenolic Acid
1
Moxifloxacin
1
Morphine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Polycythemia Vera
×
Alemtuzumab
×
Clear all
NCT00069992
2012-10-10
MPDMDSBMT
Baylor College of Medicine
Phase 2
Terminated
7 enrolled